Harrow (HROW) Non Operating Income (2013 - 2025)
Harrow (HROW) recorded quarterly Non Operating Income of -$8000.0 in Q4 2025, down 113.11% quarter-over-quarter from $61000.0 in Q3 2025, and up 99.88% on a YoY basis from -$4002.4 in Q4 2024.
Harrow (HROW) Non Operating Income (2013 - 2025) Analysis & Trends
Harrow's Non Operating Income history runs 13 years deep, the most recent figure standing at -$8000.0 for Q4 2025.
- In Q4 2025, Non Operating Income rose 99.88% year-over-year to -$8000.0; the TTM figure through Dec 2025 stood at -$6.5 million (up 65.32% YoY), while the FY2025 annual figure was $47000.0, up 100.18% from the prior year.
- Non Operating Income was -$8000.0 for Q4 2025 at Harrow, down from $61000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $18.9 million in Q4 2022 to a low of -$7.9 million in Q2 2022.
- Historically, Non Operating Income has averaged -$1.2 million across 5 years, with a median of -$1.4 million in 2021.
- Biggest YoY gain for Non Operating Income was 530.23% in 2021; the steepest drop was 92320.0% in 2021.
- A 5-year view of Non Operating Income shows it stood at $14.2 million in 2021, then soared by 33.27% to $18.9 million in 2022, then plunged by 125.49% to -$4.8 million in 2023, then slumped by 38.02% to -$6.6 million in 2024, then surged by 99.88% to -$8000.0 in 2025.
- The last three Non Operating Income figures came in at -$8000.0 (Q4 2025), $61000.0 (Q3 2025), and -$6000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8,000.00 |
| Sep 30, 2025 | 61,000.00 |
| Jun 30, 2025 | -6,000.00 |
| Mar 31, 2025 | -6.55 Mn |
| Dec 31, 2024 | -6.64 Mn |
| Sep 30, 2024 | -5.52 Mn |
| Jun 30, 2024 | 46,000.00 |
| Mar 31, 2024 | -6.64 Mn |
| Dec 31, 2023 | -4.81 Mn |
| Sep 30, 2023 | -195,000.00 |
| Jun 30, 2023 | -178,000.00 |
| Mar 31, 2023 | 29,000.00 |
| Dec 31, 2022 | 18.87 Mn |
| Sep 30, 2022 | -6.34 Mn |
| Jun 30, 2022 | -7.89 Mn |
| Mar 31, 2022 | -4.54 Mn |
| Dec 31, 2021 | 14.16 Mn |
| Sep 30, 2021 | -4.61 Mn |
| Jun 30, 2021 | -51,000.00 |
| Mar 31, 2021 | -2.70 Mn |